Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109501033 | 10950103 | 3 | F | 2002 | 20160815 | 20150324 | 20160819 | EXP | US-009507513-1109USA00866 | MERCK | 0.00 | F | Y | 57.60000 | KG | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109501033 | 10950103 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, EVERY 2 WEEKS | U | 20560 | 70 | MG | TABLET | ||||||
| 109501033 | 10950103 | 2 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNKNOWN | U | 20560 | 70 | MG | TABLET | ||||||
| 109501033 | 10950103 | 3 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | UNK UNK, UNKNOWN | U | 20560 | TABLET | ||||||||
| 109501033 | 10950103 | 4 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 75 ML, EVERY 2 WEEKS | 20560 | 75 | ML | ORAL SOLUTION | |||||||
| 109501033 | 10950103 | 5 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | 70-2800, EVERY 2 WEEKS | 0 | TABLET | |||||||||
| 109501033 | 10950103 | 6 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | 70-2800, QW | 0 | TABLET | /wk | ||||||||
| 109501033 | 10950103 | 7 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 6230 | MG | U | 0 | 70 | MG | /wk | ||||
| 109501033 | 10950103 | 8 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | UNK, QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109501033 | 10950103 | 1 | Osteoporosis |
| 109501033 | 10950103 | 5 | Product used for unknown indication |
| 109501033 | 10950103 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109501033 | 10950103 | HO |
| 109501033 | 10950103 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109501033 | 10950103 | Anxiety disorder | |
| 109501033 | 10950103 | Back pain | |
| 109501033 | 10950103 | Constipation | |
| 109501033 | 10950103 | Cystocele | |
| 109501033 | 10950103 | Diverticulum intestinal | |
| 109501033 | 10950103 | Femur fracture | |
| 109501033 | 10950103 | Haematocrit decreased | |
| 109501033 | 10950103 | Haemoglobin decreased | |
| 109501033 | 10950103 | Headache | |
| 109501033 | 10950103 | Inappropriate schedule of drug administration | |
| 109501033 | 10950103 | Intramedullary rod insertion | |
| 109501033 | 10950103 | Rectocele | |
| 109501033 | 10950103 | Stress fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109501033 | 10950103 | 1 | 2002 | 2010 | 0 | |
| 109501033 | 10950103 | 2 | 200211 | 200807 | 0 | |
| 109501033 | 10950103 | 3 | 200812 | 0 | ||
| 109501033 | 10950103 | 4 | 20050103 | 20061103 | 0 | |
| 109501033 | 10950103 | 5 | 20070216 | 20080707 | 0 | |
| 109501033 | 10950103 | 6 | 20081008 | 20081224 | 0 | |
| 109501033 | 10950103 | 7 | 20090312 | 20101121 | 0 | |
| 109501033 | 10950103 | 8 | 19370217 | 0 |